 | Up a level |
Windecker, Stephan; Lopes, Renato D; Massaro, Tyler; Jones-Burton, Charlotte; Granger, Christopher B; Aronson, Ronald; Heizer, Gretchen; Goodman, Shaun G; Darius, Harald; Jones, W Schuyler; Aschermann, Michael; Brieger, David; Cura, Fernando; Engstrøm, Thomas; Fridrich, Viliam; Halvorsen, Sigrun; Huber, Kurt; Kang, Hyun-Jae; Leiva-Pons, Jose L; Lewis, Basil S; ... (2019). Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Circulation, 140(23), pp. 1921-1932. American Heart Association 10.1161/CIRCULATIONAHA.119.043308
Connolly, Stuart J; Wallentin, Lars; Ezekowitz, Michael D; Eikelboom, John; Oldgren, Jonas; Reilly, Paul A; Brueckmann, Martina; Pogue, Janice; Alings, Marco; Amerena, John V; Avezum, Alvaro; Baumgartner, Iris; Budaj, Andrzej J; Chen, Jyh-Hong; Dans, Antonio L; Darius, Harald; Di Pasquale, Giuseppe; Ferreira, Jorge; Flaker, Greg C; Flather, Marcus D; ... (2013). The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation, 128(3), pp. 237-43. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.112.001139
